This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Simon, I. Articles by Kim, N. W. Search for Related Content PubMed PubMed Citation Articles by Simon, I. Articles by Kim, N. W.

B7-H4 Is a Novel Membrane-Bound Protein and a Candidate Serum and Tissue Biomarker for Ovarian Cancer

¹ diaDexus, Inc., South San Francisco, California; ² Department of Pathology and Laboratory Medicine, Mount Sinai Hospital; and Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, Ontario, Canada

Requests for reprints: Iris Simon, diaDexus, Inc., 343 Oyster Point Boulevard, South San Francisco, CA 94080. Phone: 650-246-6536; Fax: 650-246-6499; E-mail: isimon{at}diadexus.com.

Using cDNA database mining strategies and real-time quantitative reverse transcription-PCR, we identified B7-H4 as a novel gene that is overexpressed in ovarian and breast cancer tissues when compared with normal tissues. The gene encodes a protein of 282 amino acids with a signal sequence, an immunoglobulin domain, and a COOH-terminal hydrophobic transmembrane domain. Immunohistochemistry experiments show plasma membrane staining in serous ovarian and breast cancer, confirming the tissue specificity and cell surface localization. We have developed a sensitive dual monoclonal antibody sandwich ELISA to analyze the level of B7-H4 protein in >2,500 serum samples, ascites fluids, and tissue lysates. High levels of B7-H4 protein were detected in ovarian cancer tissue lysates when compared with normal tissues. B7-H4 was present at low levels in all sera but showed an elevated level in serum samples from ovarian cancer patients when compared with healthy controls or women with benign gynecologic diseases. The median B7-H4 concentration in endometrioid and serous histotypes was higher than in mucinous histotypes, consistent with results of immunohistochemical staining. The multivariate logistic regression analysis of B7-H4 and CA125 measured in the same sample set resulted in an area under the curve (AUC) of 0.86 for all stages and 0.86 for stage I/II patients, which was significantly higher than the AUC for either marker alone. In early-stage patients, the sensitivity at 97% specificity increased from 52% for CA125 alone to 65% when used in combination with B7-H4. We conclude that B7-H4 is a promising new biomarker for ovarian carcinoma. (Cancer Res 2006; 66(3): 1570-5)

This article has been cited by other articles:

				G. Zhu, M. M. Augustine, T. Azuma, L. Luo, S. Yao, S. Anand, A. C. Rietz, J. Huang, H. Xu, A. S. Flies, et al. B7-H4-deficient mice display augmented neutrophil-mediated innate immunity Blood, February 19, 2009; 113(8): 1759 - 1767. [Abstract] [Full Text] [PDF]

				R. H. Thompson, X. Zang, C. M. Lohse, B. C. Leibovich, S. F. Slovin, V. E. Reuter, J. C. Cheville, M. L. Blute, P. Russo, E. D. Kwon, et al. Serum-Soluble B7x Is Elevated in Renal Cell Carcinoma Patients and Is Associated with Advanced Stage Cancer Res., August 1, 2008; 68(15): 6054 - 6058. [Abstract] [Full Text] [PDF]

				D. Jackson, R. A. Craven, R. C. Hutson, I. Graze, P. Lueth, R. P. Tonge, J. L. Hartley, J. A. Nickson, S. J. Rayner, C. Johnston, et al. Proteomic Profiling Identifies Afamin as a Potential Biomarker for Ovarian Cancer Clin. Cancer Res., December 15, 2007; 13(24): 7370 - 7379. [Abstract] [Full Text] [PDF]

				Y. Zheng, D. Katsaros, S. J.C. Shan, I. R. de la Longrais, M. Porpiglia, A. Scorilas, N. W. Kim, R. L. Wolfert, I. Simon, L. Li, et al. A Multiparametric Panel for Ovarian Cancer Diagnosis, Prognosis, and Response to Chemotherapy Clin. Cancer Res., December 1, 2007; 13(23): 6984 - 6992. [Abstract] [Full Text] [PDF]

				I. Kryczek, S. Wei, G. Zhu, L. Myers, P. Mottram, P. Cheng, L. Chen, G. Coukos, and W. Zou Relationship between B7-H4, Regulatory T Cells, and Patient Outcome in Human Ovarian Carcinoma Cancer Res., September 15, 2007; 67(18): 8900 - 8905. [Abstract] [Full Text] [PDF]

				W.-K. Suh, S. Wang, G. S. Duncan, Y. Miyazaki, E. Cates, T. Walker, B. U. Gajewska, E. Deenick, W. Dawicki, H. Okada, et al. Generation and Characterization of B7-H4/B7S1/B7x-Deficient Mice. Mol. Cell. Biol., September 1, 2006; 26(17): 6403 - 6411. [Abstract] [Full Text] [PDF]